APHA - Aphria Inc.

NYSE - NYSE Delayed Price. Currency in USD
6.68
+0.20 (+3.09%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close6.48
Open6.55
Bid6.51 x 1200
Ask0.00 x 1800
Day's Range6.24 - 6.70
52 Week Range3.75 - 16.86
Volume3,951,622
Avg. Volume6,836,504
Market Cap1.671B
Beta (3Y Monthly)3.67
PE Ratio (TTM)22.34
EPS (TTM)0.30
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Aphria a Buy?
    Motley Fool1 hour ago

    Is Aphria a Buy?

    This beaten-down Canadian marijuana stock faces big risks -- but it could also deliver big rewards.

  • Investors Fret Over Pot Stocks Going Up in Smoke
    Bloomberg7 hours ago

    Investors Fret Over Pot Stocks Going Up in Smoke

    In separate addresses, the governors of New York and New Jersey each said they’ll make legalization of recreational cannabis a priority for 2019, potentially opening up a new market with a combined population of close to 30 million. Perhaps more importantly for the future of the industry, U.S. Attorney General nominee William Barr said he’ll respect state marijuana laws even though he personally disapproves of legalization. It’s a far cry from his predecessor Jeff Sessions, who once told a Senate hearing that “good people don’t smoke marijuana” then rescinded an Obama-era policy that took a hands-off approach to the drug.

  • GlobeNewswire2 days ago

    APHRIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aphria Inc. - APHA

    Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 4, 2019 to file lead plaintiff applications in a securities class action lawsuit against Aphria Inc. (APHA), if they purchased the Company’s securities between July 17, 2018 and December 4, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York. If you purchased securities of Aphria and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-apha/ to learn more.

  • GlobeNewswire2 days ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aphria Inc. of Class Action Lawsuit and Upcoming Deadline – APHA

    NEW YORK, Jan. 18, 2019 -- Pomerantz LLP announces that a class action lawsuit has been filed against Aphria Inc. (“Aphria” or the “Company”) (NYSE: APHA) and certain of its.

  • ACCESSWIRE2 days ago

    Stocks That Have Momentum and Strength

    HENDERSON, NV / ACCESSWIRE / January 18, 2019 / The biggest profit opportunities are usually found buying stocks at or near their bottoms. The old saying goes ''buy low, sell high''. Here are some ''buy ...

  • ACCESSWIRE2 days ago

    SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Aphria Inc. - APHA

    NEW YORK, NY / ACCESSWIRE / January 18, 2019 / Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aphria Inc. (APHA) from July 17, 2018 through December 4, 2018, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Aphria investors under the federal securities laws. To join the Aphria class action, go to http://pawarlawgroup.com/cases/aphria-inc/ or call Vik Pawar, Esq.

  • ACCESSWIRE2 days ago

    IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aphria Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / January 18, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aphria Inc. ("Aphria" or "the Company") (NYSE: APHA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between July 17, 2018 and December 4, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before February 4, 2019.

  • ACCESSWIRE2 days ago

    These 4 Marijuana Stocks May Surpass Investor Expectations

    CORAL GABLES, FL / ACCESSWIRE / January 18, 2019 / Marijuana stocks have been making big waves for some time now, but the last few weeks have remained especially positive for the industry. With the introduction of the US Farm Bill and the advent of legal hemp, cannabis stocks have seen impressive gains over the last month or so, with no signs of slowing down. As we head into the last few weeks of January, Premier Health Group (OTC:PHGRF) (CSE:PHGI), HEXO Corp (OTC PINK: HYYDF), Innovative Industrial Properties Inc (IIPR) and Aphria Inc (NYSE: APHA, TSX: APHA) are for pot stocks worth keeping tabs on.

  • Benzinga2 days ago

    CIBC Initiates Coverage On Cannabis Stocks, Sees Bright Future Ahead

    Cannabis investors may be witnessing the rare birth of an entirely new industry , and one Wall Street analyst said Friday three companies will emerge as the leaders of the new cannabis market. The Analyst ...

  • ACCESSWIRE2 days ago

    Best Way to Play the Cannabis Rebound

    HENDERSON, NV / ACCESSWIRE / January 18, 2019 / After some struggles in 2018, cannabis stocks are back in full force in 2019. Many stocks have erased their losses, or close to it. One cannabis play that ...

  • GlobeNewswire2 days ago

    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action Against Aphria, Inc. (APHA) & Lead Plaintiff Deadline: February 4, 2019

    Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aphria, Inc. ("Aphria" or the “Company") (APHA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aphria securities between July 17, 2018 and December 4, 2018, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/apha. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

  • GlobeNewswire2 days ago

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PPDAI, Boeing, Ternium, and Aphria and Encourages Investors to Contact the Firm

    NEW YORK, Jan. 18, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of PPDAI Group Inc., The.

  • PR Newswire2 days ago

    Aphria and UNOapp to Partner on Technology and Analytics Solutions for the Adult-Use Cannabis Industry

    LEAMINGTON, ON, Jan. 18, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has recently entered into an exclusive agreement (the "Agreement") with Toronto-based UNOapp Inc. ("UNOapp") to collaborate on the development of technology and analytics solutions for Canada's adult-use cannabis industry. "With our innovation-focused approach, Aphria is setting the pace for the evolution of the adult-use cannabis industry in Canada," said Jakob Ripshtein, President of Aphria.

  • Aphria and UNOapp to Partner on Technology and Analytics Solutions for the Adult-Use Cannabis Industry
    CNW Group2 days ago

    Aphria and UNOapp to Partner on Technology and Analytics Solutions for the Adult-Use Cannabis Industry

    LEAMINGTON, ON , Jan. 18, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) has recently entered into an exclusive agreement (the "Agreement") with Toronto -based UNOapp Inc. ("UNOapp") to collaborate on the development of technology and analytics solutions for Canada's adult-use cannabis industry. "With our innovation-focused approach, Aphria is setting the pace for the evolution of the adult-use cannabis industry in Canada ," said Jakob Ripshtein, President of Aphria.

  • GlobeNewswire3 days ago

    FEBRUARY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aphria Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aphria Inc. (“Aphria” or “the Company”) (NYSE: APHA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

  • GlobeNewswire3 days ago

    Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Aphria Inc.

    Glancy Prongay & Murray LLP (“GPM”) reminds investors of the February 4, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Aphria Inc. (“Aphria” or the “Company”) (NYSE: APHA) (Note only the US listed shares are covered by this class action) securities between July 17, 2018 and December 4, 2018, inclusive (the ''Class Period''). Aphria investors have until February 4, 2019 to file a lead plaintiff motion. On December 3, 2018, Quintessential Capital Management and Hindenburg Research published a report alleging, among other things, that the Company’s recent acquisitions in Latin America were part of a series of transactions designed to enrich Company insiders and that these acquisitions lacked established operations.

  • InvestorPlace3 days ago

    You Can Trust Aurora Cannabis Stock Despite the Dilution

    At a time when rivals Tilray (NASDAQ:TLRY) and Aphria (NYSE:APHA) have captured headlines, Aurora Cannabis (NYSE:ACB) finally got a piece of the action again. Earlier this week, management announced its acquisition of premium-cannabis producer Whistler Medical Marijuana. As expected, ACB stock jumped on the news. More importantly for speculators, the enthusiasm hasn't faded yet, despite that we're now near the end of the week. A significant reason why Wall Street remains bullish is the acquisition's fundamental impact. For the most part, Aurora Cannabis stock is a direct play in medical marijuana. With Whistler, ACB has a broader portfolio. In addition, management must keep pace with key competitors. One of the biggest announcements in the sector was the partnership between Cronos Group (NASDAQ:CRON) and Altria Group (NYSE:MO). We all know about beverage-maker Constellation Brands' (NYSE:STZ) investment in Canopy Growth (NYSE:CGC). If you're not cutting deals in this sector, you're going nowhere. InvestorPlace - Stock Market News, Stock Advice & Trading Tips That's all fine and well. The most worrying factor here, however, is dilution in ACB stock. Including Whistler, Aurora has bought out nine companies. Ordinarily, such actions represent a strain on resources. The leadership team sidesteps the issue with all-stock purchases. * Top 10 Global Stock Ideas for 2019 From RBC Capital Last year, ACB acquired MedReleaf, Anandia Labs and ICC Labs. In total, the medical-cannabis firm spent $3.6 billion, all in equity. Because management refuses to tap into their cash reserves, Aurora Cannabis stock must take the hit, no pun intended. Currently, we have 994 million shares of ACB stock outstanding. Just two years ago, we had 313 million shares outstanding. By the time the Whistler deal and possible others are completed, we're looking at well over one billion shares. For those long Aurora, this dilutive strategy warrants concern. Still, it's too early to get pessimistic. ### With ACB Stock, Focus on the 'Why,' Not the 'How' Again, under ordinary circumstances, I'd sound the alarm on Aurora Cannabis stock. Diluting shares is a relatively easy way to expand your footprint. But get it wrong, and you could be courting disaster. Even without considering a worst-case scenario, dilutive strategies invite profitability and sustainability pressures. So what makes ACB stock different? It's all about the inherent nature of the legal-marijuana industry. Unlike almost every other market, cannabis has practically appeared out of nowhere. To deliver long-term success, companies must do everything they can to establish their brand. Therefore, traditional concerns like profitability take a backseat to growth and expansion. Logically, this strategy negatively impacts investments like ACB stock in the nearer-term. However, I'm afraid no other practical alternatives exist. Like crystal meth or hallucinogenic mushrooms, making weed is relatively easy. Thanks to platforms like YouTube, you can practice "pharmacy." But due to legalization, the black-market effect no longer bolsters marijuana prices. Therefore, cannabis firms must consolidate to survive as an industry. That's one reason why I'm not panicking over dilution in Aurora Cannabis stock. The other reason is differentiation. As I just mentioned, weed is easy to grow. What will separate the contenders from the pretenders is product quality. If you look at Whistler's product portfolio, you can see why management pulled the trigger. Contrary to prior eras, cannabis has dramatically evolved from just a means to get high. Today, medical-marijuana firms have "scienced" the snot out of the underlying commodity. In the foreseeable future, we'll enjoy a standardized industry where patients can match their symptoms with an ameliorating cannabis strain. To get there, ACB must lay down the foundations. That's why investors should focus on the "why" (in this case, future profitability), not the "how" (dilution). ### Be Carefully Optimistic Toward Aurora Cannabis Stock While I agree with management's overall direction, that doesn't guarantee a smooth ride. Analysts who raise the dilution concern aren't wrong. Every action has a reaction. At the very least, each share of ACB stock will be increasingly worth less. But I highly doubt that shares will become worthless. The deal-making and dilution represent the marijuana industry's harsh realities. Due to low barriers of entry on the production side, current cannabis firms must expand, partially to discourage competitors. And because traditional financiers are iffy about marijuana's Schedule I classification, for sector players, cash is king. Otherwise, going all-equity on every acquisition is unnecessarily risky. But again, that's just the reality. This investment category isn't for everyone because we know ahead of time that it's insanely and inevitably volatile. But a careful, longer-term approach to Aurora Cannabis stock should pay off quite nicely. As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Growth Stocks With the Future Written All Over Them * 7 Reasons Why Buffett's Bet on Apple Stock Is a Good One * 10 Companies That Could Post Decelerating Profits Compare Brokers The post You Can Trust Aurora Cannabis Stock Despite the Dilution appeared first on InvestorPlace.

  • ACCESSWIRE4 days ago

    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aphria Inc. of Class Action Lawsuit and Upcoming Deadline – APHA

    NEW YORK, NY / ACCESSWIRE / January 16, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Aphria Inc. ("Aphria" or the "Company") (APHA) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and indexed under 18-cv-11427, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired Aphria securities between October 18, 2018, and December 3, 2018, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

  • ACCESSWIRE4 days ago

    IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aphria Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    LOS ANGELES, CA / ACCESSWIRE / January 16, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aphria Inc. ("Aphria" or "the Company") (NYSE: APHA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between July 17, 2018 and December 4, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before February 4, 2019.

  • GlobeNewswire4 days ago

    Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Aphria Inc. Investors

    Important Deadline Reminder:  Investors who purchased Aphria securities during the Class Period may, no later than February 4, 2019, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this action please visit www.ktmc.com/aphria-securities-class-action.

  • ACCESSWIRE4 days ago

    SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action Against Aphria, Inc. (APHA) and Lead Plaintiff Deadline - February 4, 2019

    NEW YORK, NY / ACCESSWIRE / January 16, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aphria, Inc. ("Aphria" or the "Company") (NYSE: APHA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aphria securities between July 17, 2018 and December 4, 2018, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

  • Why Marijuana ETF is on a High in 2019
    Zacks4 days ago

    Why Marijuana ETF is on a High in 2019

    After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback this year on the renewed appeal for riskier assets.

  • Pot Stock Aphria Takes the First Step to Regaining Investors' Trust
    Motley Fool4 days ago

    Pot Stock Aphria Takes the First Step to Regaining Investors' Trust

    However, there's still a long road to walk before shareholders can trust management again.

  • ACCESSWIRE4 days ago

    Cannabis Companies Investors are Watching

    Clean Spark, Inc. (CLSK) has the best in class microgrid solution for the cannabis industry. Today we are highlighting: CleanSpark, Inc. (CLSK), The Alkaline Water Company (WTER), Aphria, Inc. (NYSE: APHA), CV Sciences, Inc. (CVSI), and KushCo Holdings, Inc. (KSHB). The $3.5bn cannabis industry is one of the nation's most energy intensive, often demanding 24-hour indoor lighting rigs, heating, ventilation and air-conditioning systems at multiplying grow sites.

  • 3 Marijuana Stocks to Watch Now
    Motley Fool5 days ago

    3 Marijuana Stocks to Watch Now

    These top marijuana stocks could have market-moving news on deck soon.